Behme; Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for Behme; Christopher.The latest application filed is for "substituted azoanthracene derivatives and intermediates for preparation thereof".

Company Profile

0.14.13

Behme; Christopher - Jamestown NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted azoanthracene derivatives and intermediates for preparation thereof Grant 9,175,003 - Mjalli , et al. November 3, 2	2015-11-03
Oxadiazoanthracene compounds for the treatment of diabetes Grant 9,120,813 - Mjalli , et al. September 1, 2	2015-09-01
Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof App 20150148539 - Mjalli; Adnan M.M. ; et al.	2015-05-28
Oxadiazoanthracene Compounds for the Treatment of Diabetes App 20150087640 - Mjalli; Adnan M.M. ; et al.	2015-03-26
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,987,295 - Mjalli , et al. March 24, 2	2015-03-24
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,933,222 - Mjalli , et al. January 13, 2	2015-01-13
Oxadiazoanthracene Compounds for the Treatment of Diabetes App 20140187769 - Mjalli; Adnan M.M. ; et al.	2014-07-03
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,703,766 - Mjalli , et al. April 22, 2	2014-04-22
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20130317015 - Mjalli; Adnan M.M. ; et al.	2013-11-28
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,524,708 - Mjalli , et al. September 3, 2	2013-09-03
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20130096150 - Mjalli; Adnan M.M. ; et al.	2013-04-18
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,383,644 - Mjalli , et al. February 26, 2	2013-02-26
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, And Methods Of Use Thereof App 20110160198 - Mjalli; Adnan M.M. ; et al.	2011-06-30
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,906,507 - Mjalli , et al. March 15, 2	2011-03-15
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20110039837 - Mjalli; Adnan M.M. ; et al.	2011-02-17
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20100324033 - Mjalli; Adnan M.M. ; et al.	2010-12-23
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,790,714 - Mjalli , et al. September 7, 2	2010-09-07
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20100197677 - Mjalli; Adnan M.M. ; et al.	2010-08-05
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,727,983 - Mjalli , et al. June 1, 2	2010-06-01
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20090306063 - Mjalli; Adnan M.M. ; et al.	2009-12-10
Aryl and heteroaryl compounds, compositions, and methods of use Grant 7,544,699 - Mjalli , et al. June 9, 2	2009-06-09
Aryl and heteroaryl compounds and methods to modulate coagulation App 20060276518 - Mjalli; Adnan M. M. ; et al.	2006-12-07
Aryl and heteroaryl compounds and methods to modulate coagulation Grant 7,122,580 - Mjalli , et al. October 17, 2	2006-10-17
Aryl and heteroaryl compounds, compositions, and methods of use App 20050059705 - Mjalli, Adnan M.M. ; et al.	2005-03-17
Aryl and heteroaryl compounds and methods to modulate coagulation App 20040110832 - Mjalli, Adnan M.M. ; et al.	2004-06-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.